AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean Sells 24,510 Shares

AirSculpt Technologies, Inc. (NASDAQ:AIRS) CEO Dennis Dean sold 24,510 shares of the business’s stock in a transaction dated Friday, November 15th. The stock was sold at an average price of $6.54, for a total value of $160,295.40. Following the transaction, the chief executive officer now directly owns 582,052 shares of the company’s stock, valued at $3,806,620.08. The trade was a 4.04 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Dennis Dean also recently made the following trade(s):

• On Wednesday, November 13th, Dennis Dean sold 7,719 shares of AirSculpt Technologies stock. The shares were sold at an average price of $7.53, for a total transaction of $58,124.07.

AirSculpt Technologies Price Performance

AIRS opened at $6.51 on Friday. The company has a current ratio of 0.51, a quick ratio of 0.86 and a debt-to-equity ratio of 0.80. The stock has a market capitalization of $376.81 million, a P/E ratio of -46.50 and a beta of 1.57. The stock has a 50-day moving average price of $5.55 and a 200-day moving average price of $4.75. AirSculpt Technologies, Inc. has a 12-month low of $2.92 and a 12-month high of $9.20.

AirSculpt Technologies (NASDAQ:AIRS) last issued its earnings results on Friday, November 8th. The company reported ($0.10) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.05). The firm had revenue of $42.55 million during the quarter, compared to analysts’ expectations of $42.49 million. AirSculpt Technologies had a positive return on equity of 2.22% and a negative net margin of 4.13%. During the same period in the prior year, the company earned ($0.01) EPS. Equities analysts predict that AirSculpt Technologies, Inc. will post 0.15 earnings per share for the current fiscal year.

Hedge Funds Weigh In On AirSculpt Technologies

Several institutional investors and hedge funds have recently made changes to their positions in the business. SW Investment Management LLC lifted its stake in AirSculpt Technologies by 5.0% in the second quarter. SW Investment Management LLC now owns 4,500,000 shares of the company’s stock worth $18,000,000 after purchasing an additional 213,677 shares during the last quarter. Vanguard Group Inc. increased its holdings in shares of AirSculpt Technologies by 1.0% in the first quarter. Vanguard Group Inc. now owns 576,038 shares of the company’s stock worth $3,537,000 after buying an additional 5,606 shares during the period. Geode Capital Management LLC lifted its stake in shares of AirSculpt Technologies by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 355,540 shares of the company’s stock valued at $1,803,000 after acquiring an additional 21,339 shares during the last quarter. Barclays PLC lifted its stake in shares of AirSculpt Technologies by 227.0% in the 3rd quarter. Barclays PLC now owns 19,100 shares of the company’s stock valued at $97,000 after acquiring an additional 13,259 shares during the last quarter. Finally, FourWorld Capital Management LLC purchased a new stake in AirSculpt Technologies during the 1st quarter valued at about $557,000. Institutional investors own 91.54% of the company’s stock.

Wall Street Analyst Weigh In

Separately, BTIG Research assumed coverage on shares of AirSculpt Technologies in a report on Thursday, October 17th. They issued a “neutral” rating on the stock. Five research analysts have rated the stock with a hold rating, Based on data from MarketBeat.com, AirSculpt Technologies presently has a consensus rating of “Hold” and an average target price of $5.50.

About AirSculpt Technologies

AirSculpt Technologies, Inc, together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States. The company offers AirSculpt, a next-generation body contouring procedure that removes unwanted fat and tightens skin in a minimally invasive procedure.